Navigation Links
Immtech Reports Fiscal Second Quarter 2008 Results
Date:11/8/2007

tion fast-track status for Immtech's application to conduct a Phase III trial with pafuramidine, to treat pneumocystis pneumonia in HIV/AIDs patients.

The Company will hold a conference call on Friday, November 9, 2007 at 3:00 P.M. (EST) to present an update on the Company's progress and results for fiscal second quarter 2008 results. The User Access Code is # 23641366. Investors and interested parties in the U.S. are invited to join the call by dialing (888) 338-8374 and callers outside the U.S. should call (706) 902- 3163. Please call no later than 10 minutes prior to the scheduled start of the call to register. Information to access a recording of the conference call will be available starting on November 12th from the Immtech Pharmaceuticals web site (http://www.immtechpharma.com).

About Immtech Pharmaceuticals, Inc.

Immtech Pharmaceuticals, Inc. is focused on developing and commercializing drugs to treat infectious diseases, and the Company is expanding its targeted markets by applying its proprietary pharmaceutical platform to treat other disorders. Immtech has advanced clinical programs that include new oral treatments for pneumocystis pneumonia (PCP), malaria, and trypanosomiasis (African sleeping sickness or HAT), and a well-defined, expanding library of compounds targeting drug-resistant Gram-positive bacteria, fungal infections, Hepatitis C and other serious diseases. Immtech holds the exclusive worldwide licenses to certain patents, patent applications and technology for products derived from a proprietary pharmaceutical platform. For additional information, please go to http://www.immtechpharma.com.

"Safe Harbor" Statement under the Private Securities Reform Act of 1995: Statements in this press release regarding Immtech Pharmaceuticals, Inc.'s business, including the future prospects for PCP, which are not historical
'/>"/>

SOURCE Immtech Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. General Wesley Clark Joins Immtech as Consulting Strategic Advisor
2. US FDA Grants Orphan Drug Status to Immtechs Pafuramidine for Treatment of African Sleeping Sickness
3. Chinese SFDA Grants Immtech Fast Track Status
4. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
5. Immtech Receives $5.1 Million to Further African Sleeping Sickness Clinical Trials
6. Immtech to Present at The Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
7. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
8. Spherix Reports Second Quarter Earnings
9. Tapestry Reports Second Quarter 2007 Results
10. Callisto Reports on Second-Quarter 2007 Milestones
11. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... LONDON , July 31, 2014 ... the medical industries, announced today the incorporation of genae UK in ... Kingdom has one of the largest medical device markets ... 2012 and it is projected to increase by a CAGR of ... in 2012, equal to 9.5% of GDP. Despite recessionary pressures, market ...
(Date:7/31/2014)... YORK , July 31, 2014 ... discovering and developing better, faster and affordable treatments, ... as Senior Vice President, External Affairs. Mr. Brock ... as Head of Major Donor Relations for WWF ... In his role, Mr. Brock will guide the ...
(Date:7/31/2014)... , July 31, 2014  Genomic Health, Inc. (Nasdaq: ... host a conference call and webcast on Thursday, August 7 ... 2014 financial results.  The call and webcast will follow the ... Conference Call Details To access the live conference ... phone, please dial (877) 303-7208 from the United ...
Breaking Medicine Technology:genae Opens Offices in London 2TB Alliance Appoints Willo Brock Senior Vice President, External Affairs 2Genomic Health to Announce Second Quarter 2014 Financial Results and Host Conference Call on Thursday, August 7, 2014 2Genomic Health to Announce Second Quarter 2014 Financial Results and Host Conference Call on Thursday, August 7, 2014 3Genomic Health to Announce Second Quarter 2014 Financial Results and Host Conference Call on Thursday, August 7, 2014 4
... 27, 2012   VWR International, LLC , a global ... that it has signed an agreement to acquire ... in The Netherlands, France, Italy, Singapore, Malaysia and Vietnam. ... regulatory approval in Germany. With 30 years ...
... 2012  MetaStat, Inc. (OTCBB: MTST) announced today that ... patent applications and technology from the Albert Einstein ... license agreement covers U.S. Patent Application No. 12/998,237 ... Anti-Metastasis Treatment Efficacy"; inventors: Jeffrey Edward Segall, John ...
Cached Medicine Technology:VWR International, LLC Signs Agreement to Acquire basan Germany GmbH 2MetaStat, Inc. Executes Two New Licenses 2MetaStat, Inc. Executes Two New Licenses 3
(Date:7/31/2014)... Zensah®, a leading Miami based compression apparel company, ... , designed to help target tennis elbow, elbow tendonitis, ... for summer. The compression elbow sleeve is now available ... Zensah® fabric, the elbow sleeve is made ... no-slip cuff to ensure it stays in place, even ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 To further ... like to provide the following safety information regarding leaving ... a car can have deadly consequences. Because a child’s ... than those of adults, leaving children alone in a ... injury, and even death. , Statistics of Children Left ...
(Date:7/31/2014)... Most mommy blogs are simple family ... is to attract all mothers from all walks of ... group; whether its high fashion or child rearing. When ... on the Internet was so segmented. “I found myself ... topic and then search Google to get information on ...
(Date:7/31/2014)... A chance meeting at last April’s ASCAP “I ... Jimmy Robbins to Etymotic Research and their hearing ... in hearing wellness solutions, and maker of Music•PRO® ... Music•PRO® Electronic Earplugs have revolutionized hearing protection by ... natural hearing when hearing is not at risk. ...
(Date:7/31/2014)... News) -- Transplant surgeons often feel emotionally drained ... a new study suggests. Nearly half of ... a low sense of personal accomplishment and four ... researchers found. "Burnout is common in medicine, ... Dr. Marwan Abouljoud, director of the Henry Ford ...
Breaking Medicine News(10 mins):Health News:Compression Elbow Sleeve Provides Relief From Elbow Pain to Golfers and Tennis Players 2Health News:Compression Elbow Sleeve Provides Relief From Elbow Pain to Golfers and Tennis Players 3Health News:The Rothenberg Law Firm LLP Teams Up with Local Philadelphia TV Stations to Promote Awareness of the Dangers of Leaving Children Unattended in a Hot Vehicle 2Health News:The Rothenberg Law Firm LLP Teams Up with Local Philadelphia TV Stations to Promote Awareness of the Dangers of Leaving Children Unattended in a Hot Vehicle 3Health News:Mommylish Launches Its Website 2Health News:Country Star Jimmy Robbins Now Using Etymotic’s MusicPRO Electronic Earplugs 2Health News:Burnout Common Among Transplant Surgeons, Study Reveals 2
... measurements into account , TUESDAY, Sept. 1 (HealthDay News) -- ... & World Report list of best hospitals for heart ... failure, researchers say. , "If you really want to know ... mortality and readmission, you should look directly at government statistics ...
... flu strains , TUESDAY, Sept. 1 (HealthDay News) -- Fears ... this year may be unfounded, say researchers at the University ... the swine flu pandemic did not take a virulent turn ... did spread more rapidly than the other viruses, confirming the ...
... , , ... Board: MLSS), the recognized leader in advanced injection technologies, today ... Chairman of the Board, succeeding Leonard Osser who had previously ... has also served as the interim Chief Executive Officer since ...
... , WARSAW, Ind., Sept. 1 Zimmer Holdings, Inc. (NYSE: ... following investor conferences during the month of September: , , ... Mass., on September 9, 2009, at 11:30 a.m. Eastern Time; , ... September 14, 2009, at 8:35 a.m. Eastern Time; and , ...
... , CARDIFF, Calif., Sept. 1 ... http://www.jedimindinc.com ) announced today that their Medical Division is ... in wheelchairs. An estimated 1.6 million Americans residing outside of ... Interview Survey on Disability (NHIS-D). Jedi Mind,s Medical Division is ...
... , ... Information Association (DIA) will host Personalized Medicine: Biomarkers and Diagnostics in Drug Development, Regulatory ... , ... September 1, 2009 -- The Drug Information Association (DIA) will host ...
Cached Medicine News:Health News:Government Best Source for U.S. Hospital Data, Study Finds 2Health News:Swine Flu May Be Less Dangerous Than Predicted: Study 2Health News:Swine Flu May Be Less Dangerous Than Predicted: Study 3Health News:Milestone Scientific Announces Key Leadership Changes 2Health News:Milestone Scientific Announces Key Leadership Changes 3Health News:Jedi Mind Medical Applications Division to Concentrate on Wheelchair Mobility Applications 2Health News:DIA Conference to Explore The Science and Scope of Personalized Medicine 2
... The Leica RM2235 is a robust ... of primarily biological specimens embedded in ... backlash-free precision micrometer feed system ensures ... even when sectioning harder tissues. The ...
... biomedical and industrial applications, the Leica SM2400 ... of applications in all laboratories where paraffin ... sectioned. Its sturdy construction lends it qualities ... features of the system, such as a ...
... Automatic microtome with vibrating blade for fixed and ... as for non-biological specimen in material science ... of blade amplitude between 0,1 and 1,2 mm ... parameters can be set independently from each other. ...
... EC 350 consists of two modular units. ... surface and reaches a temperature of -15C. ... reservoir, heated dispenser nozzle, heated work surface, ... separate heated compartments for molds and cassettes. ...
Medicine Products: